AI in Biotechnology Market by Function (Drug Design & Optimisation, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply Chain, Logistics; Launch, Pricing, Patient Engagement, Adverse Events), & End User - Global Forecast to 2029

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered & Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Limitations
1.6 Stakeholders

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Insights from Primary Experts
2.2 Market Size Estimation
2.3 Data Triangulation
2.4 Market Share Estimation
2.5 Research Assumptions
2.6 Limitations
2.6.1 Methodology-Related Limitations
2.6.2 Scope-Related Limitations
2.7 Risk Assessment

4.1 AI in Biotechnology Market Overview
4.2 AI in Biotechnology Market, by Region
4.3 North America: AI in Biotechnology Market, by End-user & Region
4.4 AI in Biotechnology Market: Geographic Snapshot
4.5 AI in Biotechnology Market: Developed vs. Emerging Economies

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Cross-Industry Collaborations and Partnerships
5.2.1.2 Growing Need to Reduce Time and Cost of Drug Discovery and Development
5.2.1.3 Rising Adoption of AI in Precision Medicine
5.2.1.4 Improving Computing Power and Declining Hardware Cost
5.2.2 Restraints
5.2.2.1 High Implementation Costs of AI Limit Adoption in Biotechnology, Especially for SMEs and Emerging Economies
5.2.2.2 Data Privacy Risks and Compliance Challenges for AI in Biotechnology
5.2.3 Opportunities
5.2.3.1 Integrating AI and Big Data in Precision Medicine for Biotechnology Advancement
5.2.3.2 Surge in Biotechnology Investments Enhances Opportunities for AI to Accelerate Drug Discovery Innovations
5.2.3.3 Innovation Across Healthcare, Agriculture, and Environmental Science for Global Growth
5.2.4 Challenges
5.2.4.1 Data Quality and Interpretability Issues That Hinder AI Integration and Trustworthiness
5.2.4.2 AI Deployment in Biotechnology Hindered by Talent Shortages and Evolving Regulatory Challenges
5.3 Ecosystem Analysis
5.4 Case Study Analysis
5.4.1 Leveraged Nvidia Dgx Cloud for Rapid Training of Protein Models
5.4.2 Implemented End-To-End Ngs Workflow for Efficient Genetic Variant Detection
5.4.3 Accelerated Drug Discovery with Generative AI and Streamlined Workflows
5.5 Value Chain Analysis
5.6 Porter's Five Forces Analysis
5.6.1 Bargaining Power of Suppliers
5.6.2 Bargaining Power of Buyers
5.6.3 Threat of Substitutes
5.6.4 Threat of New Entrants
5.6.5 Intensity of Competitive Rivalry
5.7 Regulatory Analysis
5.7.1 Regulatory Landscape
5.7.1.1 North America
5.7.1.2 Europe
5.7.1.3 Asia-Pacific
5.7.1.4 Latin America
5.7.1.5 Middle East & Africa
5.7.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.8 Patent Analysis
5.8.1 Patent Publication Trends for AI in Biotechnology
5.8.2 Jurisdiction and Top Applicant Analysis
5.9 Technology Analysis
5.9.1 Key Technologies
5.9.1.1 Natural Language Processing (Nlp)
5.9.1.2 Predictive Analytics
5.9.2 Complementary Technologies
5.9.2.1 Cloud Computing
5.9.2.2 Big Data Analytics
5.10 Industry Trends
5.10.1 Evolution of AI in Biotechnology
5.10.2 Computer-Aided Drug Design and AI
5.11 Pricing Analysis
5.11.1 Indicative Pricing Analysis, by Drug Discovery Process
5.11.2 Average Selling Price Trend, by Region
5.12 Key Conferences & Events, 2024-2025
5.13 Key Stakeholders & Buying Criteria
5.13.1 Buying Criteria
5.14 Trends & Disruptions Impacting Customers’ Businesses
5.15 End-user Analysis
5.15.1 Unmet Needs
5.15.2 End-user Expectations
5.16 Investment & Funding Scenario
5.17 Impact of AI/Gen AI on AI in Biotechnology Market
5.17.1 Key Use Cases
5.17.2 Case Studies of AI/Generative AI Implementation
5.17.2.1 Case Study: Accelerated Biomarker Discovery and Clinical Trial Optimization
5.17.3 Impact of AI/Gen AI on Interconnected and Adjacent Ecosystems
5.17.3.1 Drug Discovery and Development Market
5.17.3.2 Genomics and Bioinformatics Market
5.17.3.3 Medical Imaging & Diagnostics Market
5.17.4 User Readiness & Impact Assessment
5.17.4.1 User Readiness
5.17.4.1.1 Pharmaceutical Companies
5.17.4.1.2 Biotechnology Companies
5.17.4.2 Impact Assessment
5.17.4.2.1 User A: Pharmaceutical Companies
5.17.4.2.1.1 Implementation
5.17.4.2.1.2 Impact
5.17.4.2.2 User B: Biotechnology Companies
5.17.4.2.2.1 Implementation
5.17.4.2.2.2 Impact

6.1 Introduction
6.2 End-To-End Solutions
6.2.1 Growing Use of Advanced Algorithms to Improve Precision and Efficiency to Boost Market Growth
6.3 Niche Solutions
6.3.1 Ability of Niche Solutions to Address Specific Challenges Within Drug Discovery to Support Adoption
6.4 Technologies
6.4.1 Ability of Technologies to Enhance Drug Discovery, Personalized Medicine, and Data Analytics to Fuel Growth
6.5 Services
6.5.1 Consulting Services
6.5.1.1 Increasing Efficiency of Research Processes and Cost Savings to Boost Adoption of Consulting Services
6.5.2 Implementation Services & Ongoing IT Support
6.5.2.1 Increasing Precision and Efficiency in IT Support Services to Boost Demand
6.5.3 Training & Education Services
6.5.3.1 Need for Skilled Talent to Drive Market Growth
6.5.4 Post-Sales & Maintenance Services
6.5.4.1 Complexity of AI Systems and Need for Improvement in AI Algorithms to Boost Market

7.1 Introduction
7.2 Research & Development
7.2.1 Drug Discovery
7.2.1.1 Molecular Design & Optimization
7.2.1.1.1 Increased Efficiency in Drug Discovery with Molecular Design & Optimization to Drive Market Growth
7.2.1.2 Biomarker Discovery
7.2.1.2.1 Ability to Analyze Large Data Sets with AI-Enabled Biomarker Discovery to Boost Demand For
7.2.1.3 Structure-Activity Relationship (Sar) Modeling
7.2.1.3.1 Improved Data Analysis, Predictive Modeling, and Compound Optimization for Drug Candidates with Sar to Fuel Growth
7.2.2 Clinical Development
7.2.2.1 Trial Design
7.2.2.1.1 Ability of AI to Improve Trial Design Through Simulations and Patient Stratification to Favor Market
7.2.2.2 Site Selection
7.2.2.2.1 Optimized Process of Selecting Clinical Trial Sites to Fuel Growth
7.2.2.3 Recruitment
7.2.2.3.1 Enhanced Process of Selecting and Enrolling Participants for Clinical Trials to Drive Demand
7.2.2.4 Clinical Data Assessment
7.2.2.4.1 Ability of Clinical Data Assessment to Enhance Efficiency and Accuracy of Data Interpretation to Propel Market
7.2.2.5 Predictive Toxicity & Risk Monitoring
7.2.2.5.1 Ability of Data Integration and Predictive Modeling to Create Comprehensive Risk Profiles for Drug Candidates to Support Market
7.2.2.6 Monitoring & Drug Adherence
7.2.2.6.1 Enhanced Patient Compliance with Monitoring & Drug Adherence to Drive Market Growth
7.2.2.7 Real-World Evidence (Rwe) Analysis
7.2.2.7.1 Enhanced Safety Monitoring & Economic Evaluation with Rwe Analysis to Propel Growth
7.3 Regulatory Compliance
7.3.1 Ability of AI to Ensure Regulatory Compliance in Clinical Trials to Support Growth
7.4 Manufacturing & Supply Chain
7.4.1 Supply Chain Planning
7.4.1.1 Increasing Demand for Real-Time Data Analytics to Accelerate Market Growth
7.4.2 Inventory Management
7.4.2.1 Automating Stock Tracking and Replenishment with Advanced Analytics to Fuel Growth
7.4.3 Logistics Optimization
7.4.3.1 Ability of AI to Drive Collaboration and Transparency in Biotechnology Logistics to Aid Growth
7.4.4 Demand Forecasting
7.4.4.1 Ability to Integrate Data for Reliable Demand Forecasts to Fuel Growth
7.4.5 Predictive Maintenance
7.4.5.1 Boosting Equipment Reliability with AI-Powered Predictive Maintenance to Drive Demand
7.4.6 Other Manufacturing & Supply Chain Functions
7.5 Launch & Commercial
7.5.1 Launch Coordination
7.5.1.1 Growing Product Launch Success Rates Through Predictive Analytics to Boost Adoption
7.5.2 Patient Engagement
7.5.2.1 Advantages Such as Real-Time Patient Feedback for Better Health Outcomes to Support Growth
7.5.3 Marketing Operations
7.5.3.1 Enhanced Marketing Performance with AI to Boost Market
7.5.4 Predictive Pricing
7.5.4.1 Ability of AI to Enhance Pricing Accuracy to Drive Adoption
7.6 Post-Marketing Surveillance & Patient Support
7.6.1 Medication Adherence
7.6.1.1 Growing Demand for Personalized Healthcare to Drive Market
7.6.2 Adverse Event Reporting
7.6.2.1 Advantages Such as Faster Post-Market Surveillance and Enhanced Drug Safety to Drive Demand
7.6.3 Patient Monitoring
7.6.3.1 Rise of Remote Healthcare Solutions to Boost Demand
7.6.4 Compliance Monitoring
7.6.4.1 Increasing Complexity of Regulatory Requirements to Drive Adoption
7.6.5 Patient Support Programs
7.6.5.1 Growing Interest in Patient-Centered Care to Support Growth
7.7 Corporate
7.7.1 Risk Management
7.7.1.1 Rising Expenditure for Drug Development to Support Growth
7.7.2 Compliance Monitoring
7.7.2.1 Strict Guidelines from Bodies to Aid Growth
7.7.3 Sales Force Optimization
7.7.3.1 Need for Data-Driven Decision-Making to Boost Adoption of Sales Force Optimization
7.7.4 Other Corporate Functions

8.1 Introduction
8.2 Cloud-based Solutions
8.2.1 Public Cloud
8.2.1.1 Need to Reduce Dependency on Expensive On-Premise Infrastructure to Boost Demand
8.2.2 Private Cloud
8.2.2.1 Need for Enhanced Security and Data Protection to Drive Market Growth
8.2.3 Multi-Cloud
8.2.3.1 Enhanced Flexibility & Cost Optimization to Support Market Growth
8.2.4 Hybrid Cloud
8.2.4.1 Cost Efficiency and Flexibility of Hybrid Cloud to Fuel Growth
8.3 On-Premise Solutions
8.3.1 Advantages Such as Data Security and Privacy and Compliance with Regulations to Favor Growth

9.1 Introduction
9.2 Pharmaceutical Companies
9.2.1 Innovation and Efficiency Associated with AI Integration in Drug Discovery & Development to Boost Adoption
9.3 Biotechnology Companies
9.3.1 Ability of AI-Driven Innovations to Accelerate Personalized Medicine and Drug Discovery to Support Growth
9.4 Research Institutes & Labs
9.4.1 Strategic Investments and Collaborations to Propel AI Advancements in Research Institutes and Labs
9.5 Healthcare Providers
9.5.1 Improved Patient Outcomes to Support Adoption
9.6 Contract Research Organizations (Cros)
9.6.1 Ability of AI Technologies to Accelerate Clinical Trials and Improve Patient Recruitment to Fuel Growth

10.1 Introduction
10.2 North America
10.2.1 Macroeconomic Outlook for North America
10.2.2 US
10.2.2.1 Increasing Investments and Partnerships to Drive Market
10.2.3 Canada
10.2.3.1 Availability of Advanced Facilities and Shorter Approval Times for Drug Candidates to Drive Market
10.3 Europe
10.3.1 Macroeconomic Outlook for Europe
10.3.2 Germany
10.3.2.1 Increased Funding in Start-Ups to Drive Uptake of AI in Biotechnology
10.3.3 UK
10.3.3.1 Increasing Investments and Government Fund Allocations to Drive Market
10.3.4 France
10.3.4.1 Government Initiatives in France to Support Market Growth
10.3.5 Italy
10.3.5.1 Growing Investments to Create Opportunities for Market Growth
10.3.6 Spain
10.3.6.1 Increasing Need for Personalized Medicine and Data-Driven Healthcare to Increase Adoption Rate in Market
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Macroeconomic Outlook for Asia-Pacific
10.4.2 Japan
10.4.2.1 Accelerating AI-Driven Drug Discovery and Biotechnology Innovation to Drive Market in Japan
10.4.3 China
10.4.3.1 Rising Foreign Investments to Drive Market in China
10.4.4 India
10.4.4.1 Increasing Number of Start-Ups and Support from Government to Propel Market
10.4.5 South Korea
10.4.5.1 Significant Advances in AI Integration for R&D to Fuel Growth
10.4.6 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Macroeconomic Outlook for Latin America
10.5.2 Brazil
10.5.2.1 Funding of Biotech Companies to Drive Market in Brazil
10.5.3 Mexico
10.5.3.1 Investment Inflows and Strengthening AI-Related Education to Drive Market in Mexico
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Macroeconomic Outlook for Middle East & Africa
10.6.2 GCC Countries
10.6.2.1 Increase in Healthcare Investments to Support Market Growth
10.6.3 Rest of Middle East & Africa

11.1 Introduction
11.2 Key Player Strategy/Right to Win
11.3 Revenue Analysis, 2019-2023
11.4 Market Share Analysis, 2023
11.4.1 Ranking of Key Market Players
11.5 Company Evaluation Matrix: Key Players, 2023
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
11.5.5 Company Footprint: Key Players, 2023
11.5.5.1 Company Footprint
11.5.5.2 Component Footprint
11.5.5.3 Application Footprint
11.5.5.4 End-user Footprint
11.5.5.5 Region Footprint
11.6 Company Evaluation Matrix: Start-Ups/SMEs, 2023
11.6.1 Progressive Companies
11.6.2 Responsive Companies
11.6.3 Dynamic Companies
11.6.4 Starting Blocks
11.6.5 Competitive Benchmarking: Startups/SMEs, 2023
11.7 Company Valuation & Financial Metrics
11.8 Brand/Product Comparison
11.9 Competitive Scenario
11.9.1 Product Launches & Upgrades
11.9.2 Deals
11.9.3 Expansions

12.1 Key Players
12.1.1 Nvidia Corporation
12.1.1.1 Business Overview
12.1.1.2 Products Offered
12.1.1.3 Recent Developments
12.1.1.3.1 Product Launches
12.1.1.3.2 Deals
12.1.1.4 Analyst's View
12.1.1.4.1 Right to Win
12.1.1.4.2 Strategic Choices
12.1.1.4.3 Weaknesses & Competitive Threats
12.1.2 Illumina, Inc.
12.1.2.1 Business Overview
12.1.2.2 Products Offered
12.1.2.3 Recent Developments
12.1.2.3.1 Product Launches
12.1.2.3.2 Deals
12.1.2.4 Analyst's View
12.1.2.4.1 Right to Win
12.1.2.4.2 Strategic Choices
12.1.2.4.3 Weaknesses & Competitive Threats
12.1.3 Exscientia
12.1.3.1 Business Overview
12.1.3.2 Products Offered
12.1.3.3 Recent Developments
12.1.3.3.1 Product Launches
12.1.3.3.2 Deals
12.1.3.3.3 Other Developments
12.1.3.4 Analyst's View
12.1.3.4.1 Right to Win
12.1.3.4.2 Strategic Choices
12.1.3.4.3 Weaknesses & Competitive Threats
12.1.4 Schrödinger, Inc.
12.1.4.1 Business Overview
12.1.4.2 Products Offered
12.1.4.3 Recent Developments
12.1.4.3.1 Product Upgrades
12.1.4.3.2 Deals
12.1.5 Recursion Pharmaceuticals, Inc.
12.1.5.1 Business Overview
12.1.5.2 Products Offered
12.1.5.3 Recent Developments
12.1.5.3.1 Deals
12.1.5.3.2 Expansions
12.1.6 Sophia Genetics
12.1.6.1 Business Overview
12.1.6.2 Products Offered
12.1.6.3 Recent Developments
12.1.6.3.1 Product Launches
12.1.6.3.2 Deals
12.1.7 Predictive Oncology
12.1.7.1 Business Overview
12.1.7.2 Products Offered
12.1.7.3 Recent Developments
12.1.7.3.1 Product Launches
12.1.7.3.2 Deals
12.1.8 Benevolentai
12.1.8.1 Business Overview
12.1.8.2 Products Offered
12.1.8.3 Recent Developments
12.1.8.3.1 Deals
12.1.9 Eurofins Discovery
12.1.9.1 Business Overview
12.1.9.2 Products Offered
12.1.9.3 Recent Developments
12.1.9.3.1 Product Launches
12.1.9.3.2 Deals
12.1.9.3.3 Expansions
12.1.10 Xtalpi Inc.
12.1.10.1 Business Overview
12.1.10.2 Products Offered
12.1.10.3 Recent Developments
12.1.10.3.1 Deals
12.1.11 Dnanexus, Inc.
12.1.11.1 Business Overview
12.1.11.2 Products Offered
12.1.11.3 Recent Developments
12.1.11.3.1 Deals
12.1.11.3.2 Other Developments
12.1.12 Numedii, Inc.
12.1.12.1 Business Overview
12.1.12.2 Products Offered
12.1.13 Bpgbio, Inc.
12.1.13.1 Business Overview
12.1.13.2 Products Offered
12.1.13.3 Recent Developments
12.1.13.3.1 Deals
12.1.14 Iktos.
12.1.14.1 Business Overview
12.1.14.2 Products Offered
12.1.14.3 Recent Developments
12.1.14.3.1 Deals
12.1.15 Insilico Medicine
12.1.15.1 Business Overview
12.1.15.2 Products Offered
12.1.16 Logica
12.1.16.1 Business Overview
12.1.16.2 Products Offered
12.1.17 American Chemical Society
12.1.17.1 Business Overview
12.1.17.2 Products Offered
12.1.18 Aganitha AI Inc.
12.1.18.1 Business Overview
12.1.18.2 Products Offered
12.1.18.3 Recent Developments
12.1.18.3.1 Deals
12.2 Start-Up/SME Players
12.2.1 Verisim Life
12.2.2 Valo Health
12.2.3 Tempus AI, Inc.
12.2.4 Lifebit Biotech Ltd.
12.2.5 Genoox
12.2.6 Data4Cure, Inc.
12.2.7 Deep Genomics

13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options

Table 1 Exchange Rates Utilized for Conversion to USD
Table 2 Indicative List of Collaborations and Partnerships in AI in Biotechnology Market (2021-2024)
Table 3 AI in Biotechnology Market: Porter's Five Forces Analysis
Table 4 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 5 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 6 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 7 Rest of the World: Regulatory Bodies, Government Agencies, and Other Organizations
Table 8 List of Patents/Patent Applications in AI in Biotechnology Market, 2021-2024
Table 9 AI in Biotechnology Market: Indicative Pricing, by Drug Discovery Process
Table 10 AI in Biotechnology Market: Key Conferences & Events, 2024-2025
Table 11 Influence of Stakeholders on Buying Process of Top 3 End-users (%)
Table 12 Key Buying Criteria for Top 3 End-users
Table 13 Unmet Needs in AI in Biotechnology Market
Table 14 End-user Expectations in AI in Biotechnology Market
Table 15 AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 16 AI in Biotechnology Market for End-To-End Solutions, by Region, 2022-2029 (USD Million)
Table 17 AI in Biotechnology Market for Niche Solutions, by Region, 2022-2029 (USD Million)
Table 18 AI in Biotechnology Market for Technologies, by Region, 2022-2029 (USD Million)
Table 19 AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 20 AI in Biotechnology Market for Services, by Region, 2022-2029 (USD Million)
Table 21 AI in Biotechnology Market for Consulting Services, by Region, 2022-2029 (USD Million)
Table 22 AI in Biotechnology Market for Implementation Services & Ongoing IT Support, by Region, 2022-2029 (USD Million)
Table 23 AI in Biotechnology Market for Training & Education Services, By Region, 2022-2029 (USD Million)
Table 24 AI in Biotechnology Market for Post-Sales & Maintenance Services, By Region, 2022-2029 (USD Million)
Table 25 AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 26 AI in Biotechnology Market for Research & Development Functions, By Type, 2022-2029 (USD Million)
Table 27 AI in Biotechnology Market for Research & Development Functions, By Region, 2022-2029 (USD Million)
Table 28 Examples of AI Tools Used in Drug Discovery
Table 29 AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 30 AI in Biotechnology Market for Drug Discovery, by Region, 2022-2029 (USD Million)
Table 31 AI in Biotechnology Market for Molecular Design & Optimization, By Region, 2022-2029 (USD Million)
Table 32 AI in Biotechnology Market for Biomarker Discovery, by Region, 2022-2029 (USD Million)
Table 33 AI in Biotechnology Market for Structure-Activity Relationship (Sar) Modeling, by Region, 2022-2029 (USD Million)
Table 34 AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 35 AI in Biotechnology Market for Clinical Development, by Region, 2022-2029 (USD Million)
Table 36 AI in Biotechnology Market for Trial Design, by Region, 2022-2029 (USD Million)
Table 37 AI in Biotechnology Market for Site Selection, by Region, 2022-2029 (USD Million)
Table 38 AI in Biotechnology Market for Recruitment, by Region, 2022-2029 (USD Million)
Table 39 AI in Biotechnology Market for Clinical Data Assessment, by Region, 2022-2029 (USD Million)
Table 40 AI in Biotechnology Market for Predictive Toxicity & Risk Monitoring, by Region, 2022-2029 (USD Million)
Table 41 AI in Biotechnology Market for Monitoring & Drug Adherence, By Region, 2022-2029 (USD Million)
Table 42 AI in Biotechnology Market for Real-World Evidence (Rwe) Analysis, By Region, 2022-2029 (USD Million)
Table 43 AI in Biotechnology Market for Regulatory Compliance Functions, By Region, 2022-2029 (USD Million)
Table 44 AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 45 AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Region, 2022-2029 (USD Million)
Table 46 AI in Biotechnology Market for Supply Chain Planning, by Region, 2022-2029 (USD Million)
Table 47 AI in Biotechnology Market for Inventory Management, by Region, 2022-2029 (USD Million)
Table 48 AI in Biotechnology Market for Logistics Optimization, by Region, 2022-2029 (USD Million)
Table 49 AI in Biotechnology Market for Demand Forecasting, by Region, 2022-2029 (USD Million)
Table 50 AI in Biotechnology Market for Predictive Maintenance, by Region, 2022-2029 (USD Million)
Table 51 AI in Biotechnology Market for Other Manufacturing & Supply Chain Functions, by Region, 2022-2029 (USD Million)
Table 52 AI in Biotechnology Market for Launch & Commercial Functions, By Type, 2022-2029 (USD Million)
Table 53 AI in Biotechnology Market for Launch & Commercial Functions, By Region, 2022-2029 (USD Million)
Table 54 AI in Biotechnology Market for Launch Coordination, by Region, 2022-2029 (USD Million)
Table 55 AI in Biotechnology Market for Patient Engagement, by Region, 2022-2029 (USD Million)
Table 56 AI in Biotechnology Market for Marketing Operations, by Region, 2022-2029 (USD Million)
Table 57 AI in Biotechnology Market for Predictive Pricing, by Region, 2022-2029 (USD Million)
Table 58 AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 59 AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Region, 2022-2029 (USD Million)
Table 60 AI in Biotechnology Market for Medication Adherence, by Region, 2022-2029 (USD Million)
Table 61 AI in Biotechnology Market for Adverse Event Reporting, by Region, 2022-2029 (USD Million)
Table 62 AI in Biotechnology Market for Patient Monitoring, by Region, 2022-2029 (USD Million)
Table 63 AI in Biotechnology Market for Compliance Monitoring, by Region, 2022-2029 (USD Million)
Table 64 AI in Biotechnology Market for Patient Support Programs, by Region, 2022-2029 (USD Million)
Table 65 AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 66 AI in Biotechnology Market for Corporate Functions, by Region, 2022-2029 (USD Million)
Table 67 AI in Biotechnology Market for Risk Management, by Region, 2022-2029 (USD Million)
Table 68 AI in Biotechnology Market for Compliance Monitoring, by Region, 2022-2029 (USD Million)
Table 69 AI in Biotechnology Market for Sales Force Optimization, by Region, 2022-2029 (USD Million)
Table 70 AI in Biotechnology Market for Other Corporate Functions, by Region, 2022-2029 (USD Million)
Table 71 AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 72 AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 73 AI in Biotechnology Market for Cloud-based Solutions, by Region, 2022-2029 (USD Million)
Table 74 AI in Biotechnology Market for Public Cloud, by Region, 2022-2029 (USD Million)
Table 75 AI in Biotechnology Market for Private Cloud, by Region, 2022-2029 (USD Million)
Table 76 AI in Biotechnology Market for Multi-Cloud, by Region, 2022-2029 (USD Million)
Table 77 AI in Biotechnology Market for Hybrid Cloud, by Region, 2022-2029 (USD Million)
Table 78 AI in Biotechnology Market for On-Premise Solutions, by Region, 2022-2029 (USD Million)
Table 79 AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 80 AI in Biotechnology Market for Pharmaceutical Companies, by Region, 2022-2029 (USD Million)
Table 81 AI in Biotechnology Market for Biotechnology Companies, by Region, 2022-2029 (USD Million)
Table 82 AI in Biotechnology Market for Research Institutes & Labs, by Region, 2022-2029 (USD Million)
Table 83 AI in Biotechnology Market for Healthcare Providers, by Region, 2022-2029 (USD Million)
Table 84 AI in Biotechnology Market for Contract Research Organizations (Cros), by Region, 2022-2029 (USD Million)
Table 85 AI in Biotechnology Market, by Region, 2022-2029 (USD Million)
Table 86 North America: AI in Biotechnology Market, by Country, 2022-2029 (USD Million)
Table 87 North America: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 88 North America: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 89 North America: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 90 North America: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 91 North America: AI in Biotechnology Market for Drug Discovery, By Type, 2022-2029 (USD Million)
Table 92 North America: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 93 North America: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 94 North America: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 95 North America: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 96 North America: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 97 North America: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 98 North America: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 99 North America: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 100 US: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 101 US: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 102 US: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 103 US: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 104 US: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 105 US: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 106 US: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 107 US: AI in Biotechnology Market for Launch & Commercial Functions, By Type, 2022-2029 (USD Million)
Table 108 US: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 109 US: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 110 US: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 111 US: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 112 US: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 113 Canada: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 114 Canada: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 115 Canada: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 116 Canada: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 117 Canada: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 118 Canada: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 119 Canada: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 120 Canada: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 121 Canada: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 122 Canada: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 123 Canada: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 124 Canada: AI in Biotechnology Market for Cloud-based Solutions, By Type, 2022-2029 (USD Million)
Table 125 Canada: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 126 Europe: AI in Biotechnology Market, by Country, 2022-2029 (USD Million)
Table 127 Europe: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 128 Europe: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 129 Europe: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 130 Europe: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 131 Europe: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 132 Europe: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 133 Europe: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 134 Europe: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 135 Europe: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 136 Europe: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 137 Europe: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 138 Europe: AI in Biotechnology Market for Cloud-based Solutions, By Type, 2022-2029 (USD Million)
Table 139 Europe: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 140 Germany: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 141 Germany: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 142 Germany: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 143 Germany: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 144 Germany: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 145 Germany: AI in Biotechnology Market for Clinical Development, By Type, 2022-2029 (USD Million)
Table 146 Germany: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 147 Germany: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 148 Germany: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 149 Germany: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 150 Germany: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 151 Germany: AI in Biotechnology Market for Cloud-based Solutions, By Type, 2022-2029 (USD Million)
Table 152 Germany: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 153 UK: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 154 UK: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 155 UK: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 156 UK: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 157 UK: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 158 UK: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 159 UK: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 160 UK: AI in Biotechnology Market for Launch & Commercial Functions, By Type, 2022-2029 (USD Million)
Table 161 UK: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 162 UK: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 163 UK: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 164 UK: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 165 UK: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 166 France: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 167 France: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 168 France: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 169 France: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 170 France: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 171 France: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 172 France: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 173 France: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 174 France: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 175 France: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 176 France: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 177 France: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 178 France: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 179 Italy: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 180 Italy: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 181 Italy: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 182 Italy: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 183 Italy: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 184 Italy: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 185 Italy: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 186 Italy: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 187 Italy: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 188 Italy: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 189 Italy: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 190 Italy: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 191 Italy: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 192 Spain: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 193 Spain: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 194 Spain: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 195 Spain: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 196 Spain: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 197 Spain: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 198 Spain: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 199 Spain: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 200 Spain: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 201 Spain: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 202 Spain: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 203 Spain: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 204 Spain: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 205 Rest of Europe: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 206 Rest of Europe: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 207 Rest of Europe: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 208 Rest of Europe: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 209 Rest of Europe: AI in Biotechnology Market for Drug Discovery, By Type, 2022-2029 (USD Million)
Table 210 Rest of Europe: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 211 Rest of Europe: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 212 Rest of Europe: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 213 Rest of Europe: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 214 Rest of Europe: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 215 Rest of Europe: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 216 Rest of Europe: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 217 Rest of Europe: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 218 Asia-Pacific: AI in Biotechnology Market, by Country, 2022-2029 (USD Million)
Table 219 Asia-Pacific: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 220 Asia-Pacific: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 221 Asia-Pacific: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 222 Asia-Pacific: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 223 Asia-Pacific: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 224 Asia-Pacific: AI in Biotechnology Market for Clinical Development, By Type, 2022-2029 (USD Million)
Table 225 Asia-Pacific: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 226 Asia-Pacific: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 227 Asia-Pacific: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 228 Asia-Pacific: AI in Biotechnology Market for Corporate Functions, By Type, 2022-2029 (USD Million)
Table 229 Asia-Pacific: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 230 Asia-Pacific: AI in Biotechnology Market for Cloud-based Solutions, By Type, 2022-2029 (USD Million)
Table 231 Asia-Pacific: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 232 Japan: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 233 Japan: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 234 Japan: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 235 Japan: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 236 Japan: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 237 Japan: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 238 Japan: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 239 Japan: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 240 Japan: AI in Biotechnology Market, by Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 241 Japan: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 242 Japan: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 243 Japan: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 244 Japan: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 245 China: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 246 China: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 247 China: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 248 China: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 249 China: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 250 China: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 251 China: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 252 China: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 253 China: AI in Biotechnology Market, by Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 254 China: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 255 China: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 256 China: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 257 China: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 258 India: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 259 India: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 260 India: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 261 India: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 262 India: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 263 India: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 264 India: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 265 India: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 266 India: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 267 India: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 268 India: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 269 India: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 270 India: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 271 South Korea: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 272 South Korea: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 273 South Korea: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 274 South Korea: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 275 South Korea: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 276 South Korea: AI in Biotechnology Market for Clinical Development, By Type, 2022-2029 (USD Million)
Table 277 South Korea: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 278 South Korea: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 279 South Korea: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 280 South Korea: AI in Biotechnology Market for Corporate Functions, By Type, 2022-2029 (USD Million)
Table 281 South Korea: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 282 South Korea: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 283 South Korea: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 284 Rest of Asia-Pacific: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 285 Rest of Asia-Pacific: AI in Biotechnology Market for Services, By Type, 2022-2029 (USD Million)
Table 286 Rest of Asia-Pacific: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 287 Rest of Asia-Pacific: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 288 Rest of Asia-Pacific: AI in Biotechnology Market for Drug Discovery, By Type, 2022-2029 (USD Million)
Table 289 Rest of Asia-Pacific: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 290 Rest of Asia-Pacific: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 291 Rest of Asia-Pacific: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 292 Rest of Asia-Pacific: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 293 Rest of Asia-Pacific: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 294 Rest of Asia-Pacific: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 295 Rest of Asia-Pacific: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 296 Rest of Asia-Pacific: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 297 Latin America: AI in Biotechnology Market, by Country, 2022-2029 (USD Million)
Table 298 Latin America: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 299 Latin America: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 300 Latin America: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 301 Latin America: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 302 Latin America: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 303 Latin America: AI in Biotechnology Market for Clinical Development, By Type, 2022-2029 (USD Million)
Table 304 Latin America: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 305 Latin America: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 306 Latin America: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 307 Latin America: AI in Biotechnology Market for Corporate Functions, By Type, 2022-2029 (USD Million)
Table 308 Latin America: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 309 Latin America: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 310 Latin America: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 311 Brazil: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 312 Brazil: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 313 Brazil: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 314 Brazil: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 315 Brazil: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 316 Brazil: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 317 Brazil: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 318 Brazil: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 319 Brazil: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 320 Brazil: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 321 Brazil: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 322 Brazil: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 323 Brazil: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 324 Mexico: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 325 Mexico: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 326 Mexico: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 327 Mexico: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 328 Mexico: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 329 Mexico: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 330 Mexico: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 331 Mexico: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 332 Mexico: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 333 Mexico: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 334 Mexico: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 335 Mexico: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 336 Mexico: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 337 Rest of Latin America: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 338 Rest of Latin America: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 339 Rest of Latin America: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 340 Rest of Latin America: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 341 Rest of Latin America: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 342 Rest of Latin America: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 343 Rest of Latin America: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 344 Rest of Latin America: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 345 Rest of Latin America: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 346 Rest of Latin America: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 347 Rest of Latin America: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 348 Rest of Latin America: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 349 Rest of Latin America: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 350 Middle East & Africa: AI in Biotechnology Market, by Country, 2022-2029 (USD Million)
Table 351 Middle East & Africa: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 352 Middle East & Africa: AI in Biotechnology Market for Services, By Type, 2022-2029 (USD Million)
Table 353 Middle East & Africa: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 354 Middle East & Africa: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 355 Middle East & Africa: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 356 Middle East & Africa: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 357 Middle East & Africa: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 358 Middle East & Africa: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 359 Middle East & Africa: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 360 Middle East & Africa: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 361 Middle East & Africa: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 362 Middle East & Africa: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 363 Middle East & Africa: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 364 GCC Countries: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 365 GCC Countries: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 366 GCC Countries: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 367 GCC Countries: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 368 GCC Countries: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 369 GCC Countries: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 370 GCC Countries: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 371 GCC Countries: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 372 GCC Countries: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 373 GCC Countries: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 374 GCC Countries: AI in Biotechnology Market, by Deployment Mode, 2022-2029 (USD Million)
Table 375 GCC Countries: AI in Biotechnology Market for Cloud-based Solutions, by Type, 2022-2029 (USD Million)
Table 376 GCC Countries: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 377 Rest of Middle East & Africa: AI in Biotechnology Market, by Offering, 2022-2029 (USD Million)
Table 378 Rest of Middle East & Africa: AI in Biotechnology Market for Services, by Type, 2022-2029 (USD Million)
Table 379 Rest of Middle East & Africa: AI in Biotechnology Market, by Function, 2022-2029 (USD Million)
Table 380 Rest of Middle East & Africa: AI in Biotechnology Market for Research & Development Functions, by Type, 2022-2029 (USD Million)
Table 381 Rest of Middle East & Africa: AI in Biotechnology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 382 Rest of Middle East & Africa: AI in Biotechnology Market for Clinical Development, by Type, 2022-2029 (USD Million)
Table 383 Rest of Middle East & Africa: AI in Biotechnology Market for Manufacturing & Supply Chain Functions, by Type, 2022-2029 (USD Million)
Table 384 Rest of Middle East & Africa: AI in Biotechnology Market for Launch & Commercial Functions, by Type, 2022-2029 (USD Million)
Table 385 Rest of Middle East & Africa: AI in Biotechnology Market for Post-Marketing Surveillance & Patient Support Functions, by Type, 2022-2029 (USD Million)
Table 386 Rest of Middle East & Africa: AI in Biotechnology Market for Corporate Functions, by Type, 2022-2029 (USD Million)
Table 387 Rest of Middle East & Africa: AI in Biotechnology Market, By Deployment Mode, 2022-2029 (USD Million)
Table 388 Rest of Middle East & Africa: AI in Biotechnology Market for Cloud-based Solutions Mode, by Type, 2022-2029 (USD Million)
Table 389 Rest of Middle East & Africa: AI in Biotechnology Market, by End-user, 2022-2029 (USD Million)
Table 390 AI in Biotechnology: Degree of Competition
Table 391 AI in Biotechnology Market: Offering Footprint
Table 392 AI in Biotechnology Market: Function Footprint
Table 393 AI in Biotechnology Market: End-user Footprint
Table 394 AI in Biotechnology: Region Footprint
Table 395 AI in Biotechnology Market: Detailed List of Key Start-Ups/SMEs
Table 396 AI in Biotechnology: Competitive Benchmarking of Key Emerging Players/Startups
Table 397 AI in Biotechnology Market: Product Launches & Upgrades, January 2021-August 2024
Table 398 AI in Biotechnology Market: Deals, January 2021-August 2024
Table 399 AI in Biotechnology Market: Expansions, January 2021-August 2024
Table 400 Nvidia Corporation: Company Overview
Table 401 Nvidia Corporation: Products Offered
Table 402 Nvidia Corporation: Product Launches, January 2021-August 2024
Table 403 Nvidia Corporation: Deals, January 2021-August 2024
Table 404 Illumina, Inc.: Company Overview
Table 405 Illumina, Inc.: Products Offered
Table 406 Illumina, Inc.: Product Launches, January 2021-August 2024
Table 407 Illumina, Inc.: Deals, January 2021-August 2024
Table 408 Exscientia: Company Overview
Table 409 Exscientia: Products Offered
Table 410 Exscientia: Product Launches, January 2021-August 2024
Table 411 Exscientia: Deals, January 2021-August 2024
Table 412 Exscientia: Other Developments, January 2021-August 2024
Table 413 Schrödinger, Inc.: Company Overview
Table 414 Schrödinger, Inc.: Products Offered
Table 415 Schrödinger, Inc.: Product Upgrades, January 2021-August 2024
Table 416 Schrödinger, Inc.: Deals, January 2021-August 2024
Table 417 Recursion Pharmaceuticals, Inc.: Company Overview
Table 418 Recursion Pharmaceuticals, Inc.: Products Offered
Table 419 Recursion Pharmaceuticals, Inc.: Deals, January 2021-August 2024
Table 420 Recursion Pharmaceuticals, Inc.: Expansions, January 2021-August 2024
Table 421 Sophia Genetics: Company Overview
Table 422 Sophia Genetics: Products Offered
Table 423 Sophia Genetics: Product Launches, January 2021-August 2024
Table 424 Sophia Genetics: Deals, January 2021-August 2024
Table 425 Predictive Oncology: Company Overview
Table 426 Predictive Oncology: Products Offered
Table 427 Predictive Oncology: Product Launches, January 2021-August 2024
Table 428 Predictive Oncology: Deals, January 2021-August 2024
Table 429 Benevolentai: Company Overview
Table 430 Benevolentai: Products Offered
Table 431 Benevolentai: Deals, January 2021-August 2024
Table 432 Eurofins Discovery: Company Overview
Table 433 Eurofins Discovery: Products Offered
Table 434 Eurofins Discovery: Product Launches, January 2021-August 2024
Table 435 Eurofins Discovery: Deals, January 2021-August 2024
Table 436 Eurofins Discovery: Expansions, January 2021-August 2024
Table 437 Xtalpi Inc.: Company Overview
Table 438 Xtalpi Inc.: Products Offered
Table 439 Xtalpi Inc.: Deals, January 2021-August 2024
Table 440 Dnanexus, Inc.: Company Overview
Table 441 Dnanexus, Inc.: Products Offered
Table 442 Dnanexus, Inc.: Deals, January 2021-August 2024
Table 443 Dnanexus, Inc.: Other Developments, January 2021-August 2024
Table 444 Numedii, Inc.: Company Overview
Table 445 Numedii, Inc.: Products Offered
Table 446 Bpgbio, Inc.: Company Overview
Table 447 Bpgbio, Inc.: Products Offered
Table 448 Bpgbio, Inc.: Deals, January 2021-August 2024
Table 449 Iktos: Company Overview
Table 450 Iktos: Products Offered
Table 451 Iktos: Deals, January 2021-August 2024
Table 452 Insilico Medicine: Company Overview
Table 453 Insilico Medicine: Products Offered
Table 454 Logica: Company Overview
Table 455 Logica: Products Offered
Table 456 American Chemical Society: Company Overview
Table 457 American Chemical Society: Products Offered
Table 458 Aganitha AI Inc.: Company Overview
Table 459 Aganitha AI Inc.: Products Offered
Table 460 Aganitha AI Inc.: Deals, January 2021-August 2024

Figure 1 AI in Biotechnology Market Segmentation & Regional Scope
Figure 2 Research Design
Figure 3 Primary Sources
Figure 4 Breakdown of Primary Interviews (Demand Side): by Company Type, Designation, and Region
Figure 5 Market Size Estimation: Revenue Share Analysis
Figure 6 Top-Down Approach
Figure 7 AI in Biotechnology Market: CAGR Projections
Figure 8 CAGR Projections: Supply-Side Analysis
Figure 9 Data Triangulation
Figure 10 AI in Biotechnology Market, by Offering, 2024 vs. 2029 (USD Million)
Figure 11 AI in Biotechnology Market, by Function, 2024 vs. 2029 (USD Million)
Figure 12 AI in Biotechnology Market, by Deployment Mode, 2024 vs. 2029 (USD Million)
Figure 13 AI in Biotechnology Market, by End-user, 2024 vs. 2029 (USD Million)
Figure 14 AI in Biotechnology Market: Geographical Snapshot
Figure 15 Growing Focus on Cost-Effective Processes and Favorable Government Support and Funding to Drive Market
Figure 16 North America to Dominate AI in Biotechnology Market During Forecast Period
Figure 17 Pharmaceutical Companies in North America Accounted for Largest Market Share in 2023
Figure 18 India to Register Highest Growth Rate During Forecast Period
Figure 19 Emerging Economies to Register Higher Growth Rates During Forecast Period
Figure 20 AI in Biotechnology Market: Drivers, Restraints, Opportunities, And Challenges
Figure 21 AI in Biotechnology Market: Ecosystem Analysis
Figure 22 AI in Biotechnology Market: Value Chain Analysis
Figure 23 AI in Biotechnology Market: Porter's Five Forces Analysis
Figure 24 Patent Publication Trends in AI in Biotechnology Market, 2015-2024
Figure 25 Patent Analysis of AI in Biotechnology Market, January 2015-August 2024
Figure 26 Evolution of AI in Biotechnology Market
Figure 27 Influence of Stakeholders on Buying Process of Top 3 End-users
Figure 28 Key Buying Criteria for Top 3 End-users
Figure 29 Trends & Disruptions Impacting Customers’ Businesses
Figure 30 AI in Biotechnology Market: Investment & Funding Scenario
Figure 31 Market Potential of AI/Generative AI on AI in Biotechnology Solutions
Figure 32 Number of AI-Discovered Molecules in Clinical Trials
Figure 33 North America: AI in Biotechnology Market Snapshot
Figure 34 Asia-Pacific: AI in Biotechnology Market Snapshot
Figure 35 Key Developments of Major Players Between January 2021 and June 2024
Figure 36 Revenue Analysis of Key Players in AI in Biotechnology Market, 2019-2023 (USD Billion)
Figure 37 Market Share Analysis of Key Players in AI in Biotechnology Market (2023)
Figure 38 Ranking of Key Players in AI in Biotechnology Market, 2023
Figure 39 AI in Biotechnology Market: Company Evaluation Matrix (Key Players), 2023
Figure 40 AI in Biotechnology Market: Company Footprint
Figure 41 AI in Biotechnology Market: Company Evaluation Matrix (Start-Ups/SMEs), 2023
Figure 42 EV/EBITDA of Key Vendors
Figure 43 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of AI in Biotehnology Solution Vendors
Figure 44 AI in Biotechnology Market: Brand/Product Comparative Analysis
Figure 45 Nvidia Corporation: Company Snapshot (2024)
Figure 46 Illumina, Inc.: Company Snapshot (2023)
Figure 47 Exscientia: Company Snapshot (2023)
Figure 48 Schrödinger, Inc.: Company Snapshot (2023)
Figure 49 Recursion Pharmaceuticals, Inc.: Company Snapshot (2023)
Figure 50 Sophia Genetics: Company Snapshot (2022)
Figure 51 Predictive Oncology: Company Snapshot (2023)
Figure 52 Benevolentai: Company Snapshot (2023)
Figure 53 Eurofins Discovery: Company Snapshot (2023)
Figure 54 Xtalpi Inc.: Company Snapshot (2023)